Skip to main content
EJNMMI Research

Table 2 Immunohistochemical results of lung cancer and benign disease

From: [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data

Variants

Lung cancer (n = 66)

Benign disease (n = 7)

p

Integrin αvβ3 (OD)

15,020.5 (4482.6,44,455.2)

1797.8 (794.0,2943.6)

1.08E−03

CXCR4 (OD)

5120.0 (1978.0,18,460.0)

538.6 (300.0,7101.7)

0.08

CD31 (MVD)

21.9 (13.75,34.35)

9.00 (8.90,11.50)

5.56E-03

Ki-67 (%)

20.00 (7.46,40.00)

  
  1. Bold values indicate p values means there is a significance of the statistical results
  2. OD optical density, MVD microvessel density. The non-normal distribution data showed as median (interquartile range)
Back to article page